# US 2009/0270786 A1 · Methods and systems for presenting a combination treatment

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2009/0270786 A1
- Document ID: US20090270786A1
- Status: Published application
- Kind: A1
- Application number: 12/315,072
- Filed: 2008-11-26
- Published: 2009-10-29
- Earliest claimed: 2008-04-24
- Assignees: Searete LLC, a limited liability corporation of the State of Delaware
- Inventors: Roderick A. Hyde; Muriel Y. Ishikawa; Eric C. Leuthardt; Royce A. Levien; Robert W. Lord; Mark A. Malamud; Elizabeth A. Sweeney; Lowell L. Wood, JR.; Victoria Y.H. Wood
- Web page: https://patentgrep.com/patent/US20090270786A1

## CPC

- A61B 5/00: Measuring for diagnostic purposes (radiation diagnosis A61B6/00; diagnosis by ultrasonic, sonic or infrasonic waves A61B8/00); Identification of persons
- A61B 5/411: {Detecting or monitoring allergy or intolerance reactions to an allergenic agent or substance}
- A61B 5/415: {the glands, e.g. tonsils, adenoids or thymus}
- A61B 5/418: {lymph vessels, ducts or nodes}
- A61B 5/4839: {combined with drug delivery}
- A61M 31/002: {Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time (artificial gland structures or devices A61F2/022; intra-uterine contraceptive devices A61F6/14; tampons for introducing into the vagina A61F13/20, A61L15/00; suppositories or bougies for intra-vaginal or intra-uterine application A61K9/02; physical forms of medicinal preparations for sustained or differential drug release A61K9/20, A61K9/50)}
- G16H 20/10: relating to drugs or medications, e.g. for ensuring correct administration to patients
- G16H 40/20: for the management or administration of healthcare resources or facilities, e.g. managing hospital staff or surgery rooms
- A61B 5/416: {the spleen}
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA

## Abstract

Methods, computer program products, and systems are described that include accepting an indication of a schedule for administration of a bioactive agent to an individual and presenting an indication of an artificial sensory experience at least partly based on the accepting an indication of the schedule for administration of the bioactive agent to the individual.

## Claims

### Claim 1

A computer-implemented method, comprising:
accepting an indication of a schedule for administration of a bioactive agent to an individual; and
presenting an indication of an artificial sensory experience at least partly based on the accepting an indication of the schedule for administration of the bioactive agent to the individual.

### Claim at position 2

2-43. (canceled)

### Claim 44

A system, comprising:
means for accepting an indication of a schedule for administration of a bioactive agent to an individual; and
means for presenting an indication of an artificial sensory experience at least partly based on the accepting an indication of the schedule for administration of the bioactive agent to the individual.

### Claim 45 (depends on 44)

The system of claim 44, wherein the means for accepting an indication of a schedule for administration of a bioactive agent to an individual comprises:
means for accepting a bioactive agent time schedule.

### Claim 46 (depends on 44)

The system of claim 44, wherein the means for accepting an indication of a schedule for administration of a bioactive agent to an individual comprises:
means for accepting at least one of a bioactive agent delivery type or bioactive agent delivery dosage administration schedule.

### Claim 47 (depends on 44)

The system of claim 44, wherein the means for accepting an indication of a schedule for administration of a bioactive agent to an individual comprises:
means for accepting a bioactive agent loading dose.

### Claim 48 (depends on 44)

The system of claim 44, further comprising:
means for accepting an indication of at least one of a pharmacokinetic or pharmacodynamic profile of a bioactive agent.

### Claim 49 (depends on 48)

The system of claim 48, wherein the means for accepting an indication of at least one of a pharmacokinetic or pharmacodynamic profile of a bioactive agent comprises:
means for accepting an indication of a time versus concentration representation for a bioactive agent.

### Claim 50 (depends on 48)

The system of claim 48, wherein the means for accepting an indication of at least one of a pharmacokinetic or pharmacodynamic profile of a bioactive agent comprises:
means for accepting an indication of a dose versus response representation for a bioactive agent.

### Claim at position 10

51-52. (canceled)

### Claim 53 (depends on 48)

The system of claim 48, wherein the means for accepting an indication of at least one of a pharmacokinetic or pharmacodynamic profile of a bioactive agent comprises:
means for accepting a pharmacokinetic model.

### Claim 54 (depends on 53)

The system of claim 53, wherein the means for accepting a pharmacokinetic model comprises:
means for accepting a physiologically-based pharmacokinetic model.

### Claim 55

(canceled)

### Claim 56 (depends on 53)

The system of claim 53, wherein the means for accepting a pharmacokinetic model comprises:
means for accepting an output from physiologically-based pharmacokinetic modeling software.

### Claim 57 (depends on 48)

The system of claim 48, wherein the means for accepting an indication of at least one of a pharmacokinetic or pharmacodynamic profile of a bioactive agent comprises:
means for accepting pharmacokinetic profile information for a bioactive agent including at least one of an absorption characterisitic, a distribution characteristic, a metabolization characteristic, or an excretion characteristic.

### Claim 58 (depends on 48)

The system of claim 48, wherein the means for accepting an indication of at least one of a pharmacokinetic or pharmacodynamic profile of a bioactive agent comprises:
means for accepting an indication of a pharmacokinetic profile at least partly based on at least one attribute of the individual.

### Claim at position 17

59-61. (canceled)

### Claim 62 (depends on 48)

The system of claim 48, wherein the means for accepting an indication of at least one of a pharmacokinetic or pharmacodynamic profile of a bioactive agent comprises:
means for accepting at least one of a Tmin, Tmax, Cmin, or a Cmax value for the bioactive agent.

### Claim 63 (depends on 44)

The system of claim 44, wherein the means for presenting an indication of an artificial sensory experience at least partly based on the accepting an indication of the schedule for administration of the bioactive agent to the individual comprises:
means for presenting an indication of a prescribed artificial sensory experience.

### Claim at position 20

64-69. (canceled)

### Claim 70 (depends on 44)

The system of claim 44, wherein the means for presenting an indication of an artificial sensory experience at least partly based on the accepting an indication of the schedule for administration of the bioactive agent to the individual comprises:
means for utilizing an algorithm for recommending at least one artificial sensory experience.

### Claim 71 (depends on 70)

The system of claim 70, wherein the means for utilizing an algorithm for recommending at least one artificial sensory experience comprises:
means for utilizing pharmacokinetic modeling software.

### Claim 72 (depends on 70)

The system of claim 70, wherein the means for utilizing an algorithm for recommending at least one artificial sensory experience comprises:
means for utilizing pharmacodynamic modeling software.

### Claim 73 (depends on 70)

The system of claim 70, wherein the means for utilizing an algorithm for recommending at least one artificial sensory experience comprises:
means for utilizing an algorithm configured for identifying a contraindication of the artificial sensory experience.

### Claim 74 (depends on 44)

The system of claim 44, wherein the means for presenting an indication of an artificial sensory experience at least partly based on the accepting an indication of the schedule for administration of the bioactive agent to the individual comprises:
means for presenting an indication of an artificial sensory experience at least partly based on a personal medical history.

### Claim 75 (depends on 44)

The system of claim 44, wherein the means for presenting an indication of an artificial sensory experience at least partly based on the accepting an indication of the schedule for administration of the bioactive agent to the individual comprises:
means for presenting an indication of an artificial sensory experience at least partly based on experimental data.

### Claim 76 (depends on 44)

The system of claim 44, wherein the means for presenting an indication of an artificial sensory experience at least partly based on the accepting an indication of the schedule for administration of the bioactive agent to the individual comprises:
means for presenting an indication of an artificial sensory experience at least partly based on a medical reference tool.

### Claim 77 (depends on 44)

The system of claim 44, wherein the means for presenting an indication of an artificial sensory experience at least partly based on the accepting an indication of the schedule for administration of the bioactive agent to the individual comprises:
means for presenting the indication to at least one output device.

### Claim at position 29

78-79. (canceled)

### Claim 80 (depends on 44)

The system of claim 44, wherein the means for presenting an indication of an artificial sensory experience at least partly based on the accepting an indication of the schedule for administration of the bioactive agent to the individual comprises:
means for presenting the indication to a third party.

### Claim 81 (depends on 80)

The system of claim 80, wherein the means for presenting the indication to a third party comprises:
means for presenting the indication to a health care provider.

### Claim 82 (depends on 80)

The system of claim 80, wherein the means for presenting the indication to a third party comprises:
means for selectively presenting the indication only to the individual.

### Claim 83 (depends on 44)

The system of claim 44, wherein the means for accepting an indication of a schedule for administration of a bioactive agent to an individual and means for presenting an indication of an artificial sensory experience at least partly based on the accepting an indication of the schedule for administration of the bioactive agent to the individual comprises:
means for accepting the pharmacokinetic profile of immediate release oxycodone, means for accepting a prescribed administration schedule of the immediate release oxycodone to an individual, and means for presenting a prescription for engagement of the individual with a virtual world experience at times when the plasma concentration of the immediate release oxycodone is expected to be below a substantially effective level based on the pharmacokinetic profile of the immediate release oxycodone and the prescribed administration schedule of the immediate release oxycodone.

### Claim at position 34

84-86. (canceled)

### Claim 87

A system, comprising:
circuitry for accepting an indication of a schedule for administration of a bioactive agent to an individual; and
circuitry for presenting an indication of an artificial sensory experience at least partly based on the accepting an indication of the schedule for administration of the bioactive agent to the individual.

### Claim 88

A computer program product comprising:
a signal-bearing medium bearing
one or more instructions for accepting an indication of a schedule for administration of a bioactive agent to an individual; and
one or more instructions for presenting an indication of an artificial sensory experience at least partly based on the accepting an indication of the schedule for administration of the bioactive agent to the individual.

### Claim 89 (depends on 88)

The computer program product of claim 88, wherein the signal-bearing medium includes a computer-readable medium.

### Claim 90 (depends on 88)

The computer program product of claim 88, wherein the signal-bearing medium includes a recordable medium.

### Claim 91 (depends on 88)

The computer program product of claim 88, wherein the signal-bearing medium includes a communications medium.

### Claim 92

A system comprising:
a computing device; and
instructions that when executed on the computing device cause the computing device to accept an indication of a schedule for administration of a bioactive agent to an individual; and
present an indication of an artificial sensory experience at least partly based on the accepting an indication of the schedule for administration of the bioactive agent to the individual.

### Claim 93 (depends on 92)

The system of claim 92 wherein the computing device comprises:
one or more of a personal digital assistant (PDA), a personal entertainment device, a mobile phone, a laptop computer, a tablet personal computer, a networked computer, a computing system comprised of a cluster of processors, a computing system comprised of a cluster of servers, a workstation computer, and/or a desktop computer.

### Claim 94 (depends on 92)

The system of claim 92, wherein the computing device is operable to accept the at least one attribute of the at least one individual and present the indication of the at least one prescription medication and the at least one artificial sensory experience from at least one memory.
